Fetal <it>ERAP2 </it>variation is associated with preeclampsia in African Americans in a case-control study
<p>Abstract</p> <p>Background</p> <p>Preeclampsia affects 3-8% of pregnancies and is a major cause of maternal and perinatal morbidity and mortality worldwide. This complex disorder is characterized by alterations in the immune and vascular systems and involves multiple...
Main Authors: | Elovitz Michal A, Gomez Ricardo, Kusanovic Juan P, Srinivas Sindhu, York Timothy P, Hilliard DaShaunda D, Hill Lori D, Romero Roberto, Strauss Jerome F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/12/64 |
Similar Items
-
Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia.
by: Lori D Hill, et al.
Published: (2011-01-01) -
Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women
by: Leonardo Capistrano Ferreira, et al.
Published: (2021-03-01) -
The Differential Expression of ERAP1/ERAP2 and Immune Cell Activation in Pre-eclampsia
by: Kimberly Seamon, et al.
Published: (2020-03-01) -
Polymorphisms in ERAP1 and ERAP2 Genes Are Associated With Tuberculosis in the Han Chinese
by: Shuqiong Zhang, et al.
Published: (2020-11-01) -
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
by: Silvia D’Amico, et al.
Published: (2021-02-01)